Prolactin levels and adverse events in patients treated with risperidone

J Clin Psychopharmacol. 1999 Feb;19(1):57-61. doi: 10.1097/00004714-199902000-00011.

Abstract

Hyperprolactinemia is a common clinical disorder that may lead to sexual dysfunction or galactorrhea. It may arise from a variety of etiologies, including the use of antipsychotic agents, presumably because of a dopamine receptor blockade. This analysis was designed to characterize the relationship between risperidone, serum prolactin levels, and possible clinical sequelae. All data from randomized, double-blind studies of risperidone in patients with chronic schizophrenia were analyzed. The two largest studies (the North American and multinational trials) included 841 patients (259 women, 582 men) with paired prolactin level data and 1,884 patients (554 women, 1,330 men) with data on six adverse events possibly associated with increased prolactin levels (amenorrhea, galactorrhea, and decreased libido in women; erectile dysfunction, ejaculatory dysfunction, gynecomastia, and decreased libido in men). Both risperidone and haloperidol produced dose-related increases in plasma prolactin levels in men and women. Among women, the risperidone dose was not correlated with adverse events, nor were the adverse events correlated with endpoint prolactin levels. Among men, the incidence of adverse events was positively correlated with risperidone dose; however, at risperidone doses of 4 to 10 mg/day the incidence of adverse events was not significantly higher than that observed in patients receiving placebo. Furthermore, adverse events in men were unrelated to plasma prolactin levels. Risperidone-associated increase in serum prolactin levels was not significantly correlated to the emergence of possible prolactin-related side effects.

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Female
  • Galactorrhea / chemically induced
  • Galactorrhea / etiology
  • Humans
  • Male
  • Prolactin / blood*
  • Randomized Controlled Trials as Topic
  • Retrospective Studies
  • Risperidone / adverse effects*
  • Risperidone / therapeutic use
  • Schizophrenia / complications
  • Schizophrenia / drug therapy
  • Sex Characteristics

Substances

  • Antipsychotic Agents
  • Prolactin
  • Risperidone